COVID-19 Emergency Medical Supplies Enhancement Act of 2021
This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies.
The bill makes loans under the DPA subject to certain notification requirements.
A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Introduced in House
Introduced in House
Referred to the House Committee on Financial Services.
Mr. Cleaver moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H2456-2458)
DEBATE - The House proceeded with forty minutes of debate on H.R. 3125.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2456-2457)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line